ScholarIQanswers from OpenAlex & ORCID
Yong Li
ResearcherPublications, citations & collaboration network
Yong Li is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Yong Li have?
ScholarIQindexed works
Yong Li has 3,300 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Yong Li have?
ScholarIQcitation count
Yong Li has 33,341 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Yong Li?
ScholarIQh-index
Yong Li has an h-index of 83 in OpenAlex.
What is the i10-index of Yong Li?
ScholarIQi10-index
Yong Li has an i10-index of 509 in OpenAlex.
What is the ORCID of Yong Li?
ScholarIQorcid
The ORCID for Yong Li is on the source record.
What is the OpenAlex record for Yong Li?
ScholarIQopenalex
The OpenAlex for Yong Li is on the source record.
What are the most-cited papers on Yong Li?
ScholarIQmost cited works
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
Arun Sreekumar, Laila Poisson, Thekkelnaycke M. Rajendiran, Amjad Khan, Qi Cao, Jindan Yu, Bharathi Laxman, Rohit Mehra, Robert J. Lonigro, Yong Li, Mukesh K. Nyati, Aarif Ahsan, Shanker Kalyana‐Sundaram, Bo Han, Xuhong Cao, Jaeman Byun, Gilbert S. Omenn, Debashis Ghosh, Subramaniam Pennathur, Danny C. Alexander, Alvin Berger, Jeffrey R. Shuster, John T. Wei, Sooryanarayana Varambally, Chris Beecher, Arul M. Chinnaiyan
An Integrated Network of Androgen Receptor, Polycomb, and TMPRSS2-ERG Gene Fusions in Prostate Cancer Progression
Jindan Yu, Jianjun Yu, Ram S. Mani, Qi Cao, J. Chad Brenner, Xuhong Cao, Xiaoju Wang, Longtao Wu, James Li, Ming Hu, Yusong Gong, Hong Cheng, Bharathi Laxman, Adaikkalam Vellaichamy, Sunita Shankar, Yong Li, Saravana M. Dhanasekaran, Roger E. Morey, Terrence R. Barrette, Robert J. Lonigro, Scott A. Tomlins, Sooryanarayana Varambally, Zhaohui Qin, Arul M. Chinnaiyan
Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1
Chi Lam Au Yeung, Ngai-Na Co, Tetsushi Tsuruga, Tsz-Lun Yeung, Suet‐Ying Kwan, Cecilia S. Leung, Yong Li, Edward S. Lu, Kenny Kwan, Kwong‐Kwok Wong, Rosemarie Schmandt, Karen H. Lu, Samuel C. Mok
MicroRNA-155 Functions as an OncomiR in Breast Cancer by Targeting the <i>Suppressor of Cytokine Signaling 1</i> Gene
Shuai Jiang, Hong-Wei Zhang, Ming-Hua Lu, Xiao-Hong He, Yong Li, Hua Gu, Mo‐Fang Liu, En-Duo Wang
Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial
Kathleen N. Moore, Angeles Alvarez Secord, Melissa A. Geller, David S. Miller, Noelle Cloven, Gini F. Fleming, Andrea E. Wahner Hendrickson, Masoud Azodi, Paul DiSilvestro, Amit M. Oza, Mihaela Cristea, Jonathan S. Berek, John K. Chan, B.J. Rimel, Daniela Matei, Yong Li, Kaiming Sun, Katarina Luptakova, Ursula A. Matulonis, Bradley J. Monk